LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13 and 14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will bring together students, faculty, and professionals from systems engineering and healthcare disciplines, including pharmacy, dentistry, and laboratory sciences, to explore practical applications of AI and automation.
Representing LataMed AI will be Dr. Kevin Rodan Levy, Chief Executive Officer, and Carlos Pena, Chief Financial Officer. Their presentation will address the evolving role of AI in healthcare, systems engineering, digital infrastructure, and professional decision-making. The company plans to discuss how AI-supported tools may assist healthcare professionals with medical-data evaluation, clinical workflows, and operational decision-making, as well as how automation can support the organization, reliability, and efficiency of technology systems.
A key focus of the presentation will be the importance of maintaining qualified professional oversight when implementing AI. LataMed AI emphasizes that its technologies are designed to enhance human capabilities and support informed decision-making, not replace the independent judgment of healthcare professionals, engineers, laboratory personnel, or other qualified individuals.
The conference agenda will also cover integration of AI and automation into existing systems, responsible data use, privacy and information security, operational risk management, and practical considerations in developing and deploying technology in healthcare settings.
LataMed AI intends to discuss the continued development of its healthcare technology ecosystem, specifically CardioAI, PulmoAI, and NeuroAI—AI-supported platforms being developed to assist in the evaluation and management of cardiovascular, pulmonary, and neurological health information. These platforms remain subject to continued development, testing, regulatory requirements, and commercial implementation.
Dr. Levy stated, "Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America."
The company believes that engagement with educational institutions can increase awareness of emerging healthcare technologies, encourage responsible discussion about AI, and strengthen relationships with future professionals. Participation also offers LataMed AI insights into the perspectives of students, educators, researchers, and technical professionals as it continues developing digital health solutions for Latin America.
This initiative aligns with LataMed AI's broader strategy of supporting education, professional collaboration, and responsible adoption of digital healthcare infrastructure in the region. The company plans to continue evaluating opportunities to participate in academic, healthcare, and technology forums that align with its objectives.
Importantly, participation in the conference does not constitute an endorsement of LataMed AI or its technologies by Universidad Santa Maria. The event does not guarantee future research collaborations, employment arrangements, commercial relationships, technology adoption, regulatory authorization, revenue, or other financial benefits.
For additional information, interested parties can visit LataMed AI's website or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement is based on a press release issued by LataMed AI Corp. and is intended to provide shareholders and market participants with information regarding the company's business development and educational activities.
